<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Public Health Surveill</journal-id><journal-id journal-id-type="publisher-id">publichealth</journal-id><journal-id journal-id-type="index">9</journal-id><journal-title>JMIR Public Health and Surveillance</journal-title><abbrev-journal-title>JMIR Public Health Surveill</abbrev-journal-title><issn pub-type="epub">2369-2960</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v11i1e72497</article-id><article-id pub-id-type="doi">10.2196/72497</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Validation and Refinement of Scores to Predict Stroke Risk: Prospective Cohort Study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Meng</surname><given-names>Hua</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Liu</surname><given-names>Zhuo</given-names></name><degrees>MA</degrees><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pan</surname><given-names>Dongfeng</given-names></name><degrees>BM</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Su</surname><given-names>Xinya</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lu</surname><given-names>Wenwen</given-names></name><degrees>MA</degrees><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names>Xingtian</given-names></name><degrees>MA</degrees><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Geng</surname><given-names>Yuhui</given-names></name><degrees>MA</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ma</surname><given-names>Xiaojuan</given-names></name><degrees>MA</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Liang</surname><given-names>Peifeng</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff7">7</xref></contrib></contrib-group><aff id="aff1"><institution>Hubei Provincial Clinical Research Center for Alzheimer&#x2019;s Disease, Tianyou Hospital, School of Medicine, Wuhan University of Science and Technology</institution><addr-line>Wuhan</addr-line><country>China</country></aff><aff id="aff2"><institution>Brain Science and Advanced Technology Institute, Wuhan University of Science and Technology</institution><addr-line>Wuhan</addr-line><country>China</country></aff><aff id="aff3"><institution>School of Public Health, Ningxia Medical University</institution><addr-line>Yinchuan</addr-line><country>China</country></aff><aff id="aff4"><institution>Department of Emergency Medicine, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University</institution><addr-line>Yinchuan</addr-line><country>China</country></aff><aff id="aff5"><institution>Futian Center for Chronic Disease Control</institution><addr-line>Shenzhen</addr-line><country>China</country></aff><aff id="aff6"><institution>Medical Record Statistics Department, General hospital of Ningxia Medical University</institution><addr-line>Yinchuan</addr-line><country>China</country></aff><aff id="aff7"><institution>Department of Medical Affair, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical Univeristy</institution><addr-line>301 Zhengyuan North Street</addr-line><addr-line>Yinchuan</addr-line><country>China</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Mavragani</surname><given-names>Amaryllis</given-names></name></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Sanchez</surname><given-names>Travis</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Rissanen</surname><given-names>Ina L</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Zhou</surname><given-names>Xin</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Peifeng Liang, PhD, Department of Medical Affair, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical Univeristy, 301 Zhengyuan North Street, Yinchuan, 750002, China, 86 13895085519; <email>doctor_pf@126.com</email></corresp><fn fn-type="equal" id="equal-contrib1"><label>*</label><p>these authors contributed equally</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>21</day><month>8</month><year>2025</year></pub-date><volume>11</volume><elocation-id>e72497</elocation-id><history><date date-type="received"><day>11</day><month>02</month><year>2025</year></date><date date-type="rev-recd"><day>27</day><month>06</month><year>2025</year></date><date date-type="accepted"><day>04</day><month>07</month><year>2025</year></date></history><copyright-statement>&#x00A9;Hua Meng, Zhuo Liu, Dongfeng Pan, Xinya Su, Wenwen Lu, Xingtian Wang, Yuhui Geng, Xiaojuan Ma, Peifeng Liang. Originally published in JMIR Public Health and Surveillance (<ext-link ext-link-type="uri" xlink:href="https://publichealth.jmir.org">https://publichealth.jmir.org</ext-link>), 21.8.2025. </copyright-statement><copyright-year>2025</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://publichealth.jmir.org">https://publichealth.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://publichealth.jmir.org/2025/1/e72497"/><abstract><sec><title>Background</title><p>In China, the &#x201C;8+2&#x201D; stroke risk score has been widely used to identify individuals at high risk of stroke, despite insufficient evidence confirming its predictive ability for stroke events.</p></sec><sec><title>Objective</title><p>We aimed to validate the risk score&#x2019;s ability to predict the risk of stroke within a 10-year timeframe in community cohort populations and to optimize the scoring method to improve its predictive accuracy.</p></sec><sec sec-type="methods"><title>Methods</title><p>By reviewing previous literature to obtain the parameters for constructing the logistic regression model and the Rothman-Keller model, the risk threshold points of the models were determined using a sample of 100,000 participants. For this population-based cohort study, 22,259 community residents were recruited in 2013 from one urban and rural monitoring site in Ningxia, China. The occurrence of stroke was established by a combination of self-reporting and review of hospitalization electronic records (the <italic>International Statistical Classification of Diseases and Related Health Problems 10th Revision</italic>: I60-63). A logistic regression model and a Rothman-Keller model were used to refine the 8-factor stroke risk score to predict the 10-year stroke risk. The performance of the model was assessed by the area under the receiver operating characteristic curve and net reclassification improvement.</p></sec><sec sec-type="results"><title>Results</title><p>The threshold points for low and medium risk in the logistic regression model and the Rothman-Keller model are risk scores of 0.062 and 0.002, respectively. The threshold points for medium and high risk are risk scores of 0.165 and 0.005, respectively. A total of 11,692 community residents aged 40 years or older who met the inclusion criteria completed the 10-year follow-up. According to the &#x201C;8+2&#x201D; stroke risk score, the stroke incidence in the low-risk (n=8908), medium-risk (n=1074), and high-risk groups (n=1710) was 4.5%, 14.7%, and 12.3%, respectively. The logistic regression model and the Rothman-Keller model demonstrated significant differences in area under the receiver operating characteristic curve values when compared to the &#x201C;8+2&#x201D; stroke risk score (Z=2.60, <italic>P</italic>=.001; Z=3.47, <italic>P</italic>=.009, respectively). However, no significant difference was observed between the logistic regression model and the Rothman-Keller model (Z=0.688, <italic>P</italic>=.49). Relative to the risk score, the absolute net reclassification improvement of the Rothman-Keller model was 0.051 (<italic>P</italic>=.01) and of the logistic regression model was 0.010 (<italic>P</italic>=.62).</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Our study confirmed that the &#x201C;8+2&#x201D; stroke risk score does not effectively predict stroke events. But the Rothman-Keller model may enhance the ability to identify individuals at high risk for stroke. Future research should incorporate more specific biomarkers and multimodal imaging features to develop more accurate risk prediction models.</p></sec></abstract><kwd-group><kwd>stroke</kwd><kwd>Rothman-Keller model</kwd><kwd>logistics model</kwd><kwd>risk prediction</kwd><kwd>&#x201C;8+2&#x201D; stroke risk score</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The Global Burden of Disease (GBD) 2021 study found that the number of new cases of stroke increased by 70.2% from 1990 to 2021 [<xref ref-type="bibr" rid="ref1">1</xref>], highlighting a relatively insufficient emphasis on prevention, particularly in low-income countries. The number of patients with stroke in China is currently the highest in the world. Stroke is the leading cause of death and disability among adults in the country [<xref ref-type="bibr" rid="ref2">2</xref>]. China has the highest risk of stroke globally, with an overall lifetime risk of 39.9% [<xref ref-type="bibr" rid="ref3">3</xref>]. Consequently, China has implemented a series of measures to address the increasing burden of stroke, advocating for an integrated approach to stroke prevention, treatment, management, and rehabilitation [<xref ref-type="bibr" rid="ref4">4</xref>].</p><p>The National Ministry of Health of China launched a significant national project called the &#x201C;China National Stroke Screening Survey (CNSSS)&#x201D; in 2009 to tackle the challenge posed by stroke. The China Stroke Prevention Project Committee (CSPPC) was established in April 2011. Volunteers aged 40 years and older were recruited through structured face-to-face questionnaires, and the &#x201C;8+2&#x201D; risk scorecard is used to screen participants and to identify high-risk groups [<xref ref-type="bibr" rid="ref5">5</xref>]. The &#x201C;8&#x201D; refers to 8 risk factors (hypertension, heart disease, smoking, dyslipidemia, diabetes, physical inactivity, overweight, and family history of stroke [FHS]), and the &#x201C;2&#x201D; refers to transient ischemic attacks (TIAs) and previous strokes. According to the judging criteria, respondents are categorized into low-risk, medium-risk, and high-risk groups. In 2020, a total of 268,000 individuals in the high-risk group for stroke were identified across more than 240 project areas across the country [<xref ref-type="bibr" rid="ref6">6</xref>].</p><p>Risk assessment is an effective tool for identifying prevention priorities [<xref ref-type="bibr" rid="ref7">7</xref>]. The Framingham Stroke Risk Profile is recognized as one of the earliest and most widely used simple stroke risk assessment tools. However, validation studies in domestic populations have found that it tends to overestimate the actual stroke incidence to some extent [<xref ref-type="bibr" rid="ref8">8</xref>]. Since its publication, the pooled cohort risk assessment equations have also been controversial, as some external validation studies suggest that this risk assessment model may overestimate the risk of atherosclerotic cardiovascular disease [<xref ref-type="bibr" rid="ref9">9</xref>]. A study compared the performance of the Framingham cardiovascular risk equation, the pooled cohort equations, and the China-Population Attributable Risk equations in predicting the 5-year risk of atherosclerotic cardiovascular disease, including ischemic stroke. In the Uyghur and Kazakh populations, all 3 risk assessment equations consistently underestimated the risk [<xref ref-type="bibr" rid="ref10">10</xref>]. Furthermore, although the &#x201C;8+2&#x201D; risk score tool has been widely used, its predictive ability remains unclear.</p><p>Therefore, we aimed to validate the &#x201C;8+2&#x201D; stroke risk score for predicting the 10-year risk of stroke in community cohort populations, and to optimize the scoring method to improve predictive accuracy.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Data Source</title><p>This study was a cohort study. This study followed the Transparent reporting of multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) guidelines.</p><p>The cohort was part of the China Stroke High-risk Population Screening and Intervention Program (CSHPSIP), an ongoing nationwide population-based program [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref11">11</xref>]. The study participants were recruited from the screening site in the Jinfeng District of Yinchuan City, Ningxia Hui Autonomous Region. A total of 22,259 community residents were enrolled in 2013 from one urban and rural monitoring site, and the outcome ascertainment was completed in 2023. The inclusion criteria for the screening participants are individuals who are aged 40 or older, permanent residents (those who have lived in the area for 6 months or more), and those who voluntarily participate by signing an informed consent form [<xref ref-type="bibr" rid="ref12">12</xref>]. Patients younger than 40 years, those with a history of stroke or TIA, or individuals recruited after 2014 were excluded from the study cohort. The data quality control process is detailed in the <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>.</p></sec><sec id="s2-2"><title>Risk Factors Measurement</title><p>Based on the &#x201C;Stroke Screening and Prevention Technical Specifications&#x201D; promulgated by the National Health and Family Planning Commission&#x2019;s Stroke Screening and Prevention Engineering Committee, the following risk factors were assessed: hypertension, heart disease, smoking, dyslipidemia, diabetes, physical inactivity, overweight, and FHS. The detailed criteria for each risk factor are shown in Table S1 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref> which is also available on the China Stroke and Cardiovascular Disease website.</p><p>The criteria for classifying individuals into high-, medium-, and low-risk stroke groups were as follows: the high-risk group was defined as having 3 or more risk factors; the medium-risk group was characterized by 3 or less risk factors along with a history of chronic diseases (such as hypertension, diabetes, and heart disease); and the low-risk group was defined as having 3 or less risk factors without any history of chronic diseases (Table S1 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>) [<xref ref-type="bibr" rid="ref13">13</xref>]. For high-risk individuals, follow-up visits are conducted by primary health care institutions at 6 months and 12 months after the initial assessment. For moderate-risk populations, primary health care institutions conduct a single follow-up visit at 12 months to evaluate and address their associated risk factors.</p></sec><sec id="s2-3"><title>Outcome</title><p>We recorded stroke as an endpoint event by searching electronic hospitalization records in Ningxia in June 2023. Stroke was identified using the diagnostic code I60-63 from the <italic>International Statistical Classification of Diseases and Related Health Problems 10th Revision</italic> (<italic>ICD-10</italic>).</p></sec><sec id="s2-4"><title>Logistic Regression Model</title><p>Logistic regression was used to determine the odds ratios (ORs) of every risk factor for incident stroke [<xref ref-type="bibr" rid="ref14">14</xref>]. The basic equation for regression with multiple independent variables is:</p><disp-formula id="E2"><mml:math id="eqn1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mi>ln</mml:mi><mml:mo>&#x2061;</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mi>P</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x2212;</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>&#x03B1;</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x03B2;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>X</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x03B2;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>X</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mo>&#x22EF;</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x03B2;</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></disp-formula><p><italic>Y</italic> is the estimated continuous outcome; <italic>&#x03B1;</italic> is the intercept. This is considered a constant value; <italic>&#x03B2;</italic> is the beta coefficients; and <italic>X<sub>i</sub></italic> is each risk factor.</p></sec><sec id="s2-5"><title>Rothman-Keller Model</title><p>The Rothman-Keller model, initially developed by Kenneth J. Rothman and David B. Keller in the early 1970s, was designed to assess the combined impact of tobacco and alcohol consumption on the risk of oral and pharyngeal cancers [<xref ref-type="bibr" rid="ref15">15</xref>]. This model provides a statistical framework that enables researchers to quantify both the independent and joint contributions of various risk factors to disease risk. It has been adapted and applied to a wide range of health conditions and diseases, including early-onset colorectal cancer and mild cognitive impairment [<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref>]. Its flexibility in considering both additive and multiplicative effects of risk factors makes it a valuable tool for public health research and individual risk prediction.</p><p>The Rothman-Keller model uses the binomial distribution function method for risk classification. It calculates the benchmark proportion of incidence and risk scores based on the population exposure rate and OR of each risk factor. In addition, it estimates an individual&#x2019;s relative risk of developing a disease by calculating their combined risk scores. The parameters of the Rothman-Keller model are calculated as follows:</p><list list-type="order"><list-item><p>Baseline morbidity ratio (<inline-graphic xlink:href="publichealth_v11i1e72497_fig01.png"/>&#xFF09;&#xFF1A;<inline-formula><mml:math id="ieqn1"><mml:mi>&#x03C1;</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mi>O</mml:mi><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>&#x00D7;</mml:mo><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>P</mml:mi><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mi>%</mml:mi></mml:math></inline-formula></p><p><italic>P<sub>i</sub>:</italic> the exposure rate of individuals exposed to a risk factor in the whole population; <italic>OR<sub>i</sub>:</italic> the odds ratios of exposure to a risk factor; and <italic>PAR</italic>%: population attributable risk percentage.</p></list-item><list-item><p>Risk score (&#xFF09;<italic>&#xFF1A;</italic><inline-formula><mml:math id="ieqn2"><mml:mi>S</mml:mi><mml:mo>=</mml:mo><mml:mi>&#x03C1;</mml:mi><mml:mo>&#x00D7;</mml:mo><mml:mtext>O</mml:mtext><mml:msub><mml:mrow><mml:mtext>R</mml:mtext></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula></p></list-item><list-item><p>Total risk score (<inline-graphic xlink:href="publichealth_v11i1e72497_fig03.png"/>&#xFF09;&#xFF1A;<inline-graphic xlink:href="publichealth_v11i1e72497_fig04.png"/></p><p><italic>Pi:</italic> risk factor scores for S&#x2265;1, <italic>q<sub>i</sub></italic>: risk factor scores for S&#x003C;1.</p></list-item><list-item><p>Individual risk prediction score: Individual risk of stroke=the incidence of stroke &#x00D7; <inline-graphic xlink:href="publichealth_v11i1e72497_fig05.png"/>. This expected risk of stroke is a relative value because it is measured against the overall incidence rate in the population. It can help us understand whether the individual&#x2019;s likelihood of developing a stroke is higher or lower than the average level of the population.</p></list-item></list><p>The population exposure rate of every risk factor was derived from the literature [<xref ref-type="bibr" rid="ref18">18</xref>]. The OR of exposure to a risk factor was sourced from the logistic regression model. Data for 100,000 participants were randomly generated by the binomial distribution functions of risk factors collected from the literature to identify nodes of high, medium, and low risk in models. The exposure rate of a risk factor in the study population was <italic>P<sub>0</sub></italic>. We generate 100,000 random <italic>P</italic> values of 0: 1, <italic>P</italic>&#x003C;<italic>P<sub>0</sub></italic> was recorded as 1 (ie, exposure), and <italic>P</italic>&#x003E;<italic>P<sub>0</sub></italic> was recorded as 0 (ie, nonexposure). Each risk factor simulates a column of data, summarizing the exposure of 100,000 community residents to each risk factor.</p></sec><sec id="s2-6"><title>Statistical Analysis</title><sec id="s2-6-1"><title>Missing Data Interpolation</title><p>Among 11,692 participants, 1 individual did not have information on hypertension, and 2556 individuals lacked information on blood lipid levels. In accordance with previous studies [<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref>], the incomplete data for hypertension and dyslipidemia were imputed simultaneously by multiple imputations (n=25) using the R package MICE (Stef van Buuren) [<xref ref-type="bibr" rid="ref21">21</xref>]. Based on the Akaike information criterion value, 2 of the interpolation datasets were selected and the same analysis was performed on the selected interpolation dataset to identify results that were likely to be robust. The detailed data report of the other interpolation set is presented in the Tables S2-S5 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>.</p></sec><sec id="s2-6-2"><title>Model Evaluation</title><p>First, we assessed the discrimination for the Rothman-Keller model and the logistic regression model using the area under the receiver operating characteristic curve (AUC). Our primary objective was to determine whether the predictive capability of the Rothman-Keller model surpassed that of the conventional logistic regression model, particularly in a multiclassification situation. When the increase in AUC is not statistically significant, its interpretation can become challenging [<xref ref-type="bibr" rid="ref22">22</xref>-<xref ref-type="bibr" rid="ref24">24</xref>]. Therefore, in addition to the AUC, we incorporated the absolute net reclassification improvement (NRI) to evaluate the relative performance of the 2 models. If the absolute NRI is greater than 0 or less than or equal to 1, it indicates a positive improvement, showing that the predictive ability of the new index has improved compared to the old index for stroke events. Conversely, if absolute NRI is less than 0 or greater than or equal to &#x2212;1, it signifies a negative change, suggesting an improvement in the predictive ability of the new model for no stroke events. If the absolute NRI is equal to 0, it means that the new model shows no improvement. In our study, we analyzed the reclassification and absolute NRI for individuals who experienced a stroke event and those who did not. For individuals who have had a stroke, being reclassified into a higher-risk group was deemed an improvement in classification, whereas being reclassified into a lower-risk group was considered a failure.</p><p>A <italic>P</italic> value less than .05 was considered to indicate statistical significance. The statistical analyses were performed using R 4.2 software (R Core Team).</p></sec></sec><sec id="s2-7"><title>Ethical Considerations</title><p>The ethics review committee of The People&#x2019;s Hospital of Ningxia Hui Autonomous Region approved this study (approval number: 2020-KY-053). Patients provided informed consent for using the data. Data were deidentified. No compensation was provided.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Characteristics of the Study Cohort</title><p>A total of 22,259 community residents were recruited in 2013. After excluding individuals with a history of stroke (n=313), and TIA (n=384), as well as participants younger than 40 years old (n=195) and those recruited after 2014 (n=9576), 11,791 participants were included in the follow-up cohort. After a 10-year follow-up period, 99 participants were lost to follow-up. Finally, a total of 11,692 eligible participants were included in the final analysis (<xref ref-type="fig" rid="figure1">Figure 1</xref>). A total of 767 participants (6.6%) had a stroke by the end of the follow-up period. Based on the &#x201C;8+2&#x201D; stroke risk score, the 10-year stroke incidence among the 3 stroke risk groups of the community residents was as follows: low-risk group 4.47% (n=8908, 398 stroke cases); medium-risk group 14.71% (n=1074, 158 stroke cases); and high-risk group 12.34% (n=1710, 211 stroke cases) (<xref ref-type="table" rid="table1">Table 1</xref>). Kaplan-Meier survival curves are shown in Figure S1 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Study participants screening process.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="publichealth_v11i1e72497_fig06.png"/></fig><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Characteristics of participants based on different risk levels according to the &#x201C;8+2&#x201D; stroke risk score at baseline in Ningxia (N=11,692).</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Characteristics</td><td align="left" valign="bottom">All participants, N (%)</td><td align="left" valign="bottom">High-risk participants, n (%)</td><td align="left" valign="bottom">Medium-risk participants, n (%)</td><td align="left" valign="bottom">Low-risk participants, n (%)</td></tr></thead><tbody><tr><td align="left" valign="top">Total</td><td align="left" valign="top">11,692 (100)</td><td align="left" valign="top">1710 (14.6)</td><td align="left" valign="top">1074 (9.2)</td><td align="left" valign="top">8908 (76.2)</td></tr><tr><td align="left" valign="top" colspan="5">Age (years)</td></tr><tr><td align="left" valign="top">&#x2003;40&#x2010;49</td><td align="left" valign="top">5457 (46.7)</td><td align="left" valign="top">468 (27.4)</td><td align="left" valign="top">227 (21.1)</td><td align="left" valign="top">4762 (53.5)</td></tr><tr><td align="left" valign="top">&#x2003;50&#x2010;59</td><td align="left" valign="top">3298 (28.2)</td><td align="left" valign="top">600 (35.1)</td><td align="left" valign="top">318 (29.6)</td><td align="left" valign="top">2380 (26.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>60&#x2010;69</td><td align="left" valign="top">2050 (17.5)</td><td align="left" valign="top">500 (29.2)</td><td align="left" valign="top">336 (31.3)</td><td align="left" valign="top">1214 (13.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x2265;70</td><td align="left" valign="top">887 (7.6)</td><td align="left" valign="top">142 (8.3)</td><td align="left" valign="top">193 (18.0)</td><td align="left" valign="top">552 (6.2)</td></tr><tr><td align="left" valign="top" colspan="5">Sex</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Female</td><td align="left" valign="top">5797 (49.6)</td><td align="left" valign="top">919 (53.7)</td><td align="left" valign="top">608 (56.6)</td><td align="left" valign="top">4270 (47.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Male</td><td align="left" valign="top">5895 (50.4)</td><td align="left" valign="top">791 (46.3)</td><td align="left" valign="top">466 (43.4)</td><td align="left" valign="top">4638 (52.1)</td></tr><tr><td align="left" valign="top" colspan="5">District</td></tr><tr><td align="left" valign="top">&#x2003;Urban</td><td align="left" valign="top">6057 (51.8)</td><td align="left" valign="top">1212 (70.9)</td><td align="left" valign="top">189 (17.6)</td><td align="left" valign="top">4656 (52.3)</td></tr><tr><td align="left" valign="top">&#x2003;Rural</td><td align="left" valign="top">5635 (48.2)</td><td align="left" valign="top">498 (29.1)</td><td align="left" valign="top">885 (82.4)</td><td align="left" valign="top">4252 (47.7)</td></tr><tr><td align="left" valign="top" colspan="5">Family history of stroke</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">361 (3.1)</td><td align="left" valign="top">289 (16.9)</td><td align="left" valign="top">15 (1.4)</td><td align="left" valign="top">57 (0.6)</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">11,331 (96.9)</td><td align="left" valign="top">1421 (83.1)</td><td align="left" valign="top">1059 (98.6)</td><td align="left" valign="top">8851 (99.4)</td></tr><tr><td align="left" valign="top" colspan="5">Heart disease</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">461 (3.9)</td><td align="left" valign="top">265 (15.5)</td><td align="left" valign="top">196 (18.2)</td><td align="left" valign="top">0 (0)</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">11,231 (96.1)</td><td align="left" valign="top">1445 (84.5)</td><td align="left" valign="top">878 (81.8)</td><td align="left" valign="top">8908 (100)</td></tr><tr><td align="left" valign="top" colspan="5">Hypertension</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">1684 (14.4)</td><td align="left" valign="top">903 (52.8)</td><td align="left" valign="top">781 (72.7)</td><td align="left" valign="top">0 (0)</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">10,008 (85.6)</td><td align="left" valign="top">807 (47.2)</td><td align="left" valign="top">293 (27.3)</td><td align="left" valign="top">8908 (100)</td></tr><tr><td align="left" valign="top" colspan="5">Dyslipidemia</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">1639 (14.0)</td><td align="left" valign="top">1343 (78.5)</td><td align="left" valign="top">113 (10.5)</td><td align="left" valign="top">183 (2.1)</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">10,053 (86.0)</td><td align="left" valign="top">367 (21.5)</td><td align="left" valign="top">961 (89.5)</td><td align="left" valign="top">8725 (97.9)</td></tr><tr><td align="left" valign="top" colspan="5">Diabetes</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">395 (3.4)</td><td align="left" valign="top">190 (11.1)</td><td align="left" valign="top">205 (19.1)</td><td align="left" valign="top">0 (0)</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">11,297 (96.6)</td><td align="left" valign="top">1520 (88.9)</td><td align="left" valign="top">869 (80.9)</td><td align="left" valign="top">8908 (100)</td></tr><tr><td align="left" valign="top" colspan="5">Smoking</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">1355 (11.6)</td><td align="left" valign="top">439 (25.7)</td><td align="left" valign="top">92 (8.6)</td><td align="left" valign="top">824 (9.3)</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">10,337 (88.4)</td><td align="left" valign="top">1271 (74.3)</td><td align="left" valign="top">982 (91.4)</td><td align="left" valign="top">8084 (90.7)</td></tr><tr><td align="left" valign="top" colspan="5">Overweight</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">2362 (20.2)</td><td align="left" valign="top">1100 (64.3)</td><td align="left" valign="top">267 (24.9)</td><td align="left" valign="top">995 (11.2)</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">9330 (79.8)</td><td align="left" valign="top">610 (35.7)</td><td align="left" valign="top">807 (75.1)</td><td align="left" valign="top">7913 (88.8)</td></tr><tr><td align="left" valign="top" colspan="5">Physical inactivity</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">2983 (25.5)</td><td align="left" valign="top">1204 (70.4)</td><td align="left" valign="top">198 (18.4)</td><td align="left" valign="top">1581 (17.7)</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">8709 (74.5)</td><td align="left" valign="top">506 (29.6)</td><td align="left" valign="top">876 (81.6)</td><td align="left" valign="top">7327 (82.3)</td></tr></tbody></table></table-wrap></sec><sec id="s3-2"><title>Model Construction</title><p>The baseline incidence ratio (<italic>&#x03C1;</italic>) of 8 factors was obtained to calculate the population attributable risk percentage (PAR%) through a previous study [<xref ref-type="bibr" rid="ref18">18</xref>]. The OR values of these factors were assessed using a logistic regression model. The parameters of the logistic model and the Rothman-Keller model are shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Parameters of risk exposure factors in the logistic model and Rothman-Keller model.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Risk factor</td><td align="left" valign="bottom">P<sub>i</sub> <sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup></td><td align="left" valign="bottom">OR<italic><sub>i</sub></italic><sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup> (95% CI)</td><td align="left" valign="bottom">&#x03B2;<sub><italic>i</italic></sub><sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="bottom">PAR (%)<sup><xref ref-type="table-fn" rid="table2fn4">d</xref></sup></td><td align="left" valign="bottom">&#x03C1;<sup><xref ref-type="table-fn" rid="table2fn5">e</xref></sup></td><td align="left" valign="bottom">S<sup><xref ref-type="table-fn" rid="table2fn6">f</xref></sup></td></tr></thead><tbody><tr><td align="left" valign="top">Hypertension</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0.580</td><td align="left" valign="top">3.00 (2.49&#x2010;3.59)</td><td align="left" valign="top">1.097</td><td align="left" valign="top">50.5</td><td align="left" valign="top">0.495</td><td align="left" valign="top">1.485</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">0.420</td><td align="left" valign="top">1</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">0.495</td><td align="left" valign="top">0.495</td></tr><tr><td align="left" valign="top">Diabetes</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0.297</td><td align="left" valign="top">2.21 (1.67&#x2010;2.90)</td><td align="left" valign="top">.793</td><td align="left" valign="top">17.4</td><td align="left" valign="top">0.826</td><td align="left" valign="top">1.825</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">0.703</td><td align="left" valign="top">1</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">0.826</td><td align="left" valign="top">0.826</td></tr><tr><td align="left" valign="top">Dyslipidemia</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0.297</td><td align="left" valign="top">0.94 (0.76&#x2010;1.17)</td><td align="left" valign="top">&#x2013;.060</td><td align="left" valign="top">19.6</td><td align="left" valign="top">0.804</td><td align="left" valign="top">0.756</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">0.703</td><td align="left" valign="top">1</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">0.804</td><td align="left" valign="top">0.804</td></tr><tr><td align="left" valign="top">Heart diseases</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0.691</td><td align="left" valign="top">1.24 (0.89&#x2010;1.69)</td><td align="left" valign="top">.211</td><td align="left" valign="top">50.4</td><td align="left" valign="top">0.496</td><td align="left" valign="top">0.615</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">0.309</td><td align="left" valign="top">1</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">0.496</td><td align="left" valign="top">0.496</td></tr><tr><td align="left" valign="top">Smoking</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0.213</td><td align="left" valign="top">0.88 (0.69&#x2010;1.10)</td><td align="left" valign="top">&#x2013;.133</td><td align="left" valign="top">8.2</td><td align="left" valign="top">0.918</td><td align="left" valign="top">0.808</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">0.787</td><td align="left" valign="top">1</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">0.918</td><td align="left" valign="top">0.918</td></tr><tr><td align="left" valign="top">Overweight</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0.054</td><td align="left" valign="top">1.51 (1.27&#x2010;1.79)</td><td align="left" valign="top">.411</td><td align="left" valign="top">2.1</td><td align="left" valign="top">0.979</td><td align="left" valign="top">1.478</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">0.946</td><td align="left" valign="top">1</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">0.979</td><td align="left" valign="top">0.979</td></tr><tr><td align="left" valign="top">Physical inactivity</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0.515</td><td align="left" valign="top">1.01 (0.85&#x2010;1.20)</td><td align="left" valign="top">.010</td><td align="left" valign="top">34.9</td><td align="left" valign="top">0.651</td><td align="left" valign="top">0.658</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">0.485</td><td align="left" valign="top">1</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">0.651</td><td align="left" valign="top">0.651</td></tr><tr><td align="left" valign="top">Family history of stroke</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0.085</td><td align="left" valign="top">1.40 (1.01&#x2010;1.92)</td><td align="left" valign="top">.338</td><td align="left" valign="top">5.1</td><td align="left" valign="top">0.949</td><td align="left" valign="top">1.329</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">0.915</td><td align="left" valign="top">1</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">0.949</td><td align="left" valign="top">0.949</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>P<sub>i</sub>: the exposure rate of individuals exposed to a risk factor in the whole population</p></fn><fn id="table2fn2"><p><sup>b</sup>OR<sub>i</sub>: the odds ratios of exposure to a risk factor;</p></fn><fn id="table2fn3"><p><sup>c</sup> &#x03B2;<sub>i</sub> is the beta coefficient</p></fn><fn id="table2fn4"><p><sup>d</sup> PAR%: population attributed risk percentage</p></fn><fn id="table2fn5"><p><sup>e</sup>&#x03C1;<italic>:</italic> baseline morbidity ratio</p></fn><fn id="table2fn6"><p><sup>f</sup>S<italic>:</italic> risk score</p></fn></table-wrap-foot></table-wrap><p>After ranking the stroke incidence risk based on a dataset of 100,000 random entries, 2 nodes were selected for subdividing the risk groups into low-risk, medium-risk, and high-risk categories using the logistic regression model: node a (ID=25844, risk prediction score=0.06168760) and node b (ID=77778, risk prediction score=0.16451650). In addition, for the Rothman-Keller model, 2 other nodes were chosen for the same purpose: node A (ID=25426, risk prediction score=0.0021993391) and node B (ID=64553, risk prediction score =0.0047898060) (Figure S2 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>).</p></sec><sec id="s3-3"><title>Evaluation of the Model</title><p>The sensitivity, specificity, and AUC of the &#x201C;8+2&#x201D; stroke risk score, the Rothman-Keller model, and the logistic regression model are presented in <xref ref-type="table" rid="table3">Table 3</xref>. The logistic regression model and the Rothman-Keller model demonstrated significant differences in AUC values compared to the &#x201C;8+2&#x201D; stroke risk score (Z=2.60, <italic>P</italic>&#x003C;.05; Z=3.47, <italic>P</italic>&#x003C;.05, respectively). However, no difference was observed between the logistic regression model and the Rothman-Keller model (Z=0.688, <italic>P</italic>&#x003E;.05). The comparison of receiver operating characteristic curve is shown in Figure S3 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>.</p><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>The discrimination of &#x201C;8+2&#x201D; stroke risk score, logistic and Rothman-Keller model.</p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Sensitivity</td><td align="left" valign="bottom">Specificity</td><td align="left" valign="bottom">AUC<sup><xref ref-type="table-fn" rid="table3fn1">a</xref></sup> (95% CI)</td><td align="left" valign="bottom">Z value (<italic>P</italic>) <sup><xref ref-type="table-fn" rid="table3fn2">b</xref></sup></td><td align="left" valign="bottom">Z value (<italic>P</italic>)<sup><xref ref-type="table-fn" rid="table3fn3">c</xref></sup></td></tr></thead><tbody><tr><td align="left" valign="top">&#x201C;8+2&#x201D; stroke risk score</td><td align="left" valign="top">0.48</td><td align="left" valign="top">0.79</td><td align="left" valign="top">0.627 (0.619&#x2010;0.636)</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Logistic model</td><td align="left" valign="top">0.41</td><td align="left" valign="top">0.85</td><td align="left" valign="top">0.649 (0.641&#x2010;0.658)</td><td align="left" valign="top">3.47 (<italic>P</italic>=.001)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Rothman-Keller model</td><td align="left" valign="top">0.52</td><td align="left" valign="top">0.74</td><td align="left" valign="top">0.646 (0.637&#x2010;0.654)</td><td align="left" valign="top">2.60 (<italic>P</italic>=.009)</td><td align="left" valign="top">0.688 (<italic>P</italic>=.492)</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup>AUC: area under the curve</p></fn><fn id="table3fn2"><p><sup>b</sup>:Versus &#x201C;8+2&#x201D; stroke risk score;</p></fn><fn id="table3fn3"><p><sup>c</sup>:Versus logistic model</p></fn></table-wrap-foot></table-wrap><p>From the NRI, we found that the majority of participants remained at the same level of risk for developing a stroke as predicted by the &#x201C;8+2&#x201D; stroke risk score, the logistic regression model, and the Rothman-Keller model (ie, along the diagonal from the lower left to the upper right). However, some community residents were reclassified as having a different level of risk for developing stroke (Figure S4 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>). According to the &#x201C;8+2&#x201D; stroke risk score, the NRI for reclassification of stroke events by the Rothman-Keller model was 7.8%, while the NRI for nonstroke events was &#x2212;2.7%. The absolute NRI was then estimated to be 0.051 (<italic>P</italic>=.01), calculated using the sum of the net estimated for individuals who developed a stroke and those who did not. The NRI for the logistic regression model was 1.7% for stroke events and &#x2212;0.7% for nonstroke events, resulting in an absolute NRI of 0.010 (<italic>P</italic>=.62) .</p></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>This cohort study followed 11,692 individuals aged 40 years and older for a duration of 10 years. According to the &#x201C;8+2&#x201D; stroke risk score, the stroke incidence in the low-risk (n=8908), medium-risk (n=1074), and high-risk groups (n=1710) was 4.5%, 14.7%, and 12.3%, respectively. We developed a logistic regression model and a Rothman-Keller model to validate and optimize the risk score. Through a comparative analysis of the performance of the 3 models, we found that the Rothman-Keller model exhibited the best performance.</p><p>We verified the efficacy of the model using an actual database. There was no significant difference in the AUC values between the logistic regression model and the Rothman-Keller model. To evaluate model performance more accurately, we used the NRI for a more in-depth analysis. The NRI assesses the effects of low-, medium-, and high-risk reclassification for both stroke and nonstroke events, resulting in a net reclassification that provides a more accurate estimate than that obtained with other approaches [<xref ref-type="bibr" rid="ref23">23</xref>]. Positive values of the stroke NRI indicate that the model effectively identifies patients with stroke, enabling physicians to initiate targeted detection or treatment to prevent stroke events. In contrast, a decrease in the NRI for nonstroke events suggests that community residents with a low or medium risk as determined by the &#x201C;8+2&#x201D; stroke risk score may actually be at a higher risk of having a stroke. Based on the overall NRI, we conclude that the Rothman-Keller model enhances the reclassification of both stroke and nonstroke events [<xref ref-type="bibr" rid="ref25">25</xref>]. This finding aligns with the results of previous studies. Researchers used the Rothman-Keller model to predict the likelihood of mild cognitive impairment in older Chinese individuals. Upon validation with actual population data, it was found that the model had appropriate accuracy and performed well in terms of predictive efficacy [<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref26">26</xref>]. The model can be adjusted and optimized based on new research data and epidemiological changes, thereby maintaining its predictive power in a timely manner. Its methodology can be applied to risk assessments for other populations and chronic diseases, demonstrating significant universality.</p><p>There are many model studies aimed at predicting stroke risk [<xref ref-type="bibr" rid="ref27">27</xref>-<xref ref-type="bibr" rid="ref30">30</xref>]. For instance, SCORE2 is a risk assessment tool developed using extensive data from a large number of European populations. It is designed to evaluate the risk of cardiovascular disease in both men and women across 4 distinct risk areas in Europe within a 10-year period [<xref ref-type="bibr" rid="ref31">31</xref>]. While this tool is widely applied, it has limitations in terms of ethnicity and geography. Significant prediction errors may occur when applying it to populations with considerable differences [<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref32">32</xref>]. A study estimated the 10-year risk of stroke based on a cohort analysis and found that factors such as age, systolic blood pressure, diastolic blood pressure, FHS, atrial fibrillation, diabetes, and others can significantly predict the incidence of stroke [<xref ref-type="bibr" rid="ref27">27</xref>]. Compared with other models, this study developed a Rothman-Keller model based on questionnaire information to identify new risk nodes through simulation datasets, which provided a basis for stroke prevention. Furthermore, the model&#x2019;s predictive power and accuracy were verified using real-world data. Logistic regression analysis indicated that smoking, heart disease, dyslipidemia, and physical inactivity were not related to stroke, which may be attributed to variations in demographic and stroke subtypes differences. This result was consistent with the results of previous Mendelian randomization studies [<xref ref-type="bibr" rid="ref33">33</xref>-<xref ref-type="bibr" rid="ref37">37</xref>].</p><p>The limitations of this study are as follows: first, the dataset used for verification only included participants from only one region. Studies in other provinces are necessary to evaluate the efficacy of our model. When research results are extrapolated to other populations with significant differences, it may be essential to consider the exposure rates of risk factors and OR or RR values for those populations in order to update and optimize the model. This process enhances the predictive accuracy and applicability of the Rothman-Keller model. Second, we were unable to perform a subgroup analysis on the various types of stroke. The primary objective of the program is to identify and intervene with high-risk populations to prevent the occurrence of stroke or reduce its risk, rather than focusing on the subtypes of ischemic stroke and hemorrhagic stroke. Furthermore, given the limitations of medical resources and the acceptability of screening, the program may prioritize the implementation of more accessible and universal preventive measures. These measures include controlling blood pressure, quitting smoking, and increasing physical activity, all of which are effective in preventing both ischemic stroke and hemorrhagic stroke [<xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref39">39</xref>]. Third, during the decade, participants may have received lifestyle interventions, pharmaceutical treatments, and early clinical treatment that influenced the incidence of stroke events. However, in the medium- and high-risk groups for stroke, these patients represent a certain proportion. Our model primarily assesses the variations in the initial screening judgments, and the outcome events remain consistent across different models, making it unlikely to influence the study results. Finally, the low sensitivity observed in this study may be attributed to the lack of several important stroke prediction factors from the risk scoring scale, thereby limiting its predictive ability. In 2021, the Guidelines for Stroke Prevention and Treatment in China recommended including homocysteine testing in routine screening and conducting carotid artery examinations for high-risk populations when conditions permit. Our research findings further support this recommendation. Although this study has some limitations, it also presents several advantages. The diagnostic criteria for risk factors in this project are based on relevant guidelines and standards established by the China Health Commission. Staff members undergo standardized training and assessment, and only those who pass the assessment are qualified to conduct screening tasks. Therefore, the identification of risk factors in this study had high accuracy and credibility. We used the binomial distribution of risk factors to construct a random dataset of 100,000 community residents, which allowed us to determine the high-, medium-, and low-risk boundary values of the models. The variables in the model were easily obtained and predicted estimates could be derived through straightforward calculations. We included a substantial number of community residences from the CSHPSIP over a decade for external validation, which exhibited good discrimination and calibration.</p></sec><sec id="s4-2"><title>Conclusions</title><p>In conclusion, the Rothman-Keller model may improve the predictive efficacy of stroke screening models. In the future, verification will need to be carried out in a wider population and combined with more risk factors. The Rothman-Keller model for assessing individualized stroke risk, combined with interactive information platforms for health education, is beneficial for decreasing the incidence of stroke among high-risk groups.</p></sec></sec></body><back><ack><p>This work was supported by the Ningxia Natural Science Foundation (grant number 2023AAC03445) and Key R&#x0026;D Project of Ningxia Hui Autonomous Region (grant number 2021BEG03099).</p></ack><notes><sec><title>Data Availability</title><p>The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request.</p></sec></notes><fn-group><fn fn-type="con"><p>LPF and PDF conceived the study. PDF, SXY, LWW, WXT, LZ, GYH, and MXJ designed and supervised the study. MH, SXY, LWW, WXT, LZ, GYH, and MXJ participated in data collection. MH, SXY, and LPF performed the whole data integration and analysis. MH and LZ wrote the first draft of the manuscript. LPF and MH improved the research and edited the manuscript. All authors read and approved the final manuscript.</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AUC</term><def><p>area under the receiver operating characteristic curve</p></def></def-item><def-item><term id="abb2">CNSSS</term><def><p>China National Stroke Screening Survey</p></def></def-item><def-item><term id="abb3">CSHPSIP</term><def><p>China Stroke High-risk Population Screening and Intervention Program</p></def></def-item><def-item><term id="abb4">CSPPC</term><def><p>China Stroke Prevention Project Committee</p></def></def-item><def-item><term id="abb5">FHS</term><def><p>family history of stroke</p></def></def-item><def-item><term id="abb6">GBD</term><def><p>Global Burden of Disease</p></def></def-item><def-item><term id="abb7"><italic>ICD-10</italic></term><def><p><italic>International Statistical Classification of Diseases and Related Health Problems 10th Revision</italic></p></def></def-item><def-item><term id="abb8">NRI</term><def><p>net reclassification improvement</p></def></def-item><def-item><term id="abb9">TIA</term><def><p>transient ischemic attack</p></def></def-item><def-item><term id="abb10">TRIPOD</term><def><p>Transparent reporting of multivariable prediction model for Individual Prognosis or Diagnosis</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feigin</surname><given-names>VL</given-names> </name><name name-style="western"><surname>Abate</surname><given-names>MD</given-names> </name><name name-style="western"><surname>Abate</surname><given-names>YH</given-names> </name><etal/></person-group><article-title>Global, regional, and national burden of stroke and its risk factors, 1990&#x2013;2021: a systematic analysis for the Global Burden of Disease Study 2021</article-title><source>Lancet Neurol</source><year>2024</year><month>10</month><volume>23</volume><issue>10</issue><fpage>973</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(24)00369-7</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>LD</given-names> </name><name name-style="western"><surname>Peng</surname><given-names>B</given-names> </name><name name-style="western"><surname>Zhang</surname><given-names>HQ</given-names> </name><etal/></person-group><article-title>Brief report on stroke prevention and treatment in China, 2020</article-title><source>Chin J Cerebrovasc Dis</source><year>2022</year><volume>19</volume><issue>2</issue><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.3969/j.issn.1672-5921.2022.02.011</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><collab>GBD 2016 Lifetime Risk of Stroke Collaborators</collab><name name-style="western"><surname>Feigin</surname><given-names>VL</given-names> </name><name name-style="western"><surname>Nguyen</surname><given-names>G</given-names> </name><etal/></person-group><article-title>Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016</article-title><source>N Engl J Med</source><year>2018</year><month>12</month><day>20</day><volume>379</volume><issue>25</issue><fpage>2429</fpage><lpage>2437</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1804492</pub-id><pub-id pub-id-type="medline">30575491</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu</surname><given-names>WJ</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>LD</given-names> </name><collab>Special Writing Group of China Stroke Surveillance Report</collab></person-group><article-title>China stroke surveillance report 2021</article-title><source>Mil Med Res</source><year>2023</year><month>07</month><day>19</day><volume>10</volume><issue>1</issue><fpage>33</fpage><pub-id pub-id-type="doi">10.1186/s40779-023-00463-x</pub-id><pub-id pub-id-type="medline">37468952</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chao</surname><given-names>BH</given-names> </name><name name-style="western"><surname>Yan</surname><given-names>F</given-names> </name><name name-style="western"><surname>Hua</surname><given-names>Y</given-names> </name><etal/></person-group><article-title>Stroke prevention and control system in China: CSPPC-Stroke Program</article-title><source>Int J Stroke</source><year>2021</year><month>04</month><volume>16</volume><issue>3</issue><fpage>265</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1177/1747493020913557</pub-id><pub-id pub-id-type="medline">32223541</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><collab>Prevention RoS</collab><collab>Group TiCW</collab></person-group><article-title>Brief report on stroke prevention and treatment in China, 2021</article-title><source>Chinese Journal of Cerebrovascular Diseases</source><year>2023</year><volume>20</volume><issue>11</issue><fpage>783</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.3969/j.issn.1672-5921.2023.11.009</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><collab>Chinese Medical Association Branch of Neurology</collab><collab>Group of Cerebrovascular diseases</collab><collab>Branch of Neurology</collab><collab>Chinese Medical Association</collab></person-group><article-title>Expert consensus on the use of the Chinese Ischemic Stroke Risk Assessment Scale</article-title><source>Chin J Neurol</source><year>2016</year><volume>49</volume><issue>7</issue><fpage>519</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.3760/cma.j.issn.1006-7876.2016.07.003</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Fang</surname><given-names>X</given-names> </name><name name-style="western"><surname>Guan</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Validation of 10-year stroke prediction scores in a community-based cohort of Chinese older adults</article-title><source>Front Neurol</source><year>2020</year><volume>11</volume><issue>986</issue><fpage>33192957</fpage><pub-id pub-id-type="doi">10.3389/fneur.2020.00986</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X</given-names> </name><name name-style="western"><surname>Shen</surname><given-names>P</given-names> </name><name name-style="western"><surname>Zhang</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Evaluation of atherosclerotic cardiovascular risk prediction models in China: results from the CHERRY study</article-title><source>JACC Asia</source><year>2022</year><month>02</month><volume>2</volume><issue>1</issue><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jacasi.2021.10.007</pub-id><pub-id pub-id-type="medline">36340248</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Ma</surname><given-names>R</given-names> </name><name name-style="western"><surname>Guo</surname><given-names>H</given-names> </name><etal/></person-group><article-title>External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China</article-title><source>BMC Public Health</source><year>2020</year><month>12</month><volume>20</volume><issue>1</issue><fpage>32993590</fpage><pub-id pub-id-type="doi">10.1186/s12889-020-09579-4</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu</surname><given-names>W</given-names> </name><name name-style="western"><surname>Yan</surname><given-names>F</given-names> </name><name name-style="western"><surname>Chao</surname><given-names>B</given-names> </name><name name-style="western"><surname>Ji</surname><given-names>X</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>L</given-names> </name></person-group><article-title>Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program, 2018</article-title><source>Front Med</source><year>2021</year><month>12</month><volume>15</volume><issue>6</issue><fpage>903</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1007/s11684-021-0871-4</pub-id><pub-id pub-id-type="medline">34893949</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>T</given-names> </name><name name-style="western"><surname>Ma</surname><given-names>J</given-names> </name><name name-style="western"><surname>Li</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013</article-title><source>Neurology (ECronicon)</source><year>2017</year><month>07</month><day>4</day><volume>89</volume><issue>1</issue><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000004056</pub-id><pub-id pub-id-type="medline">28566547</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>J</given-names> </name><name name-style="western"><surname>Bai</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Ding</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Analysis of carotid ultrasound screening of high-risk groups of stroke based on big data technology</article-title><source>J Healthc Eng</source><year>2022</year><volume>2022</volume><issue>6363691</issue><fpage>6363691</fpage><pub-id pub-id-type="doi">10.1155/2022/6363691</pub-id><pub-id pub-id-type="medline">35126935</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoltzfus</surname><given-names>JC</given-names> </name></person-group><article-title>Logistic regression: a brief primer</article-title><source>Acad Emerg Med</source><year>2011</year><month>10</month><volume>18</volume><issue>10</issue><fpage>1099</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1111/j.1553-2712.2011.01185.x</pub-id><pub-id pub-id-type="medline">21996075</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothman</surname><given-names>K</given-names> </name><name name-style="western"><surname>Keller</surname><given-names>A</given-names> </name></person-group><article-title>The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx</article-title><source>J Chronic Dis</source><year>1972</year><month>12</month><volume>25</volume><issue>12</issue><fpage>711</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1016/0021-9681(72)90006-9</pub-id><pub-id pub-id-type="medline">4648515</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B</given-names> </name><name name-style="western"><surname>Shen</surname><given-names>T</given-names> </name><name name-style="western"><surname>Mao</surname><given-names>L</given-names> </name><name name-style="western"><surname>Xie</surname><given-names>L</given-names> </name><name name-style="western"><surname>Fang</surname><given-names>QL</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>XP</given-names> </name></person-group><article-title>Establishment of a risk prediction model for mild cognitive impairment among elderly Chinese</article-title><source>J Nutr Health Aging</source><year>2020</year><volume>24</volume><issue>3</issue><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1007/s12603-020-1335-2</pub-id><pub-id pub-id-type="medline">32115605</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>J</given-names> </name><name name-style="western"><surname>Li</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Yu</surname><given-names>J</given-names> </name><etal/></person-group><article-title>A risk scoring system to predict the individual incidence of early-onset colorectal cancer</article-title><source>BMC Cancer</source><year>2022</year><month>01</month><day>29</day><volume>22</volume><issue>1</issue><fpage>122</fpage><pub-id pub-id-type="doi">10.1186/s12885-022-09238-4</pub-id><pub-id pub-id-type="medline">35093005</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>S</given-names> </name><name name-style="western"><surname>Fang</surname><given-names>J</given-names> </name><name name-style="western"><surname>Li</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Ma</surname><given-names>M</given-names> </name><name name-style="western"><surname>Hong</surname><given-names>Y</given-names> </name><name name-style="western"><surname>He</surname><given-names>L</given-names> </name></person-group><article-title>The population attributable risk and clustering of stroke risk factors in different economical regions of China</article-title><source>Medicine (Baltimore)</source><year>2020</year><month>04</month><volume>99</volume><issue>16</issue><fpage>e19689</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000019689</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luik</surname><given-names>A</given-names> </name><name name-style="western"><surname>Radzewitz</surname><given-names>A</given-names> </name><name name-style="western"><surname>Kieser</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority FreezeAF study</article-title><source>Circulation</source><year>2015</year><month>10</month><day>6</day><volume>132</volume><issue>14</issue><fpage>1311</fpage><lpage>1319</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.016871</pub-id><pub-id pub-id-type="medline">26283655</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sterne</surname><given-names>JAC</given-names> </name><name name-style="western"><surname>White</surname><given-names>IR</given-names> </name><name name-style="western"><surname>Carlin</surname><given-names>JB</given-names> </name><etal/></person-group><article-title>Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls</article-title><source>BMJ</source><year>2009</year><month>06</month><day>29</day><volume>338</volume><fpage>b2393</fpage><pub-id pub-id-type="doi">10.1136/bmj.b2393</pub-id><pub-id pub-id-type="medline">19564179</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Buuren</surname><given-names>S</given-names> </name><name name-style="western"><surname>Groothuis-Oudshoorn</surname><given-names>K</given-names> </name></person-group><article-title>Mice: multivariate Imputation by Chained Equations in R</article-title><source>J Stat Softw</source><year>2011</year><month>12</month><volume>45</volume><issue>3</issue><fpage>1</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.18637/jss.v045.i03</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pencina</surname><given-names>MJ</given-names> </name><name name-style="western"><surname>D&#x2019;Agostino</surname><given-names>RB</given-names> </name><name name-style="western"><surname>D&#x2019;Agostino</surname><given-names>RB</given-names> </name><name name-style="western"><surname>Vasan</surname><given-names>RS</given-names> </name></person-group><article-title>Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond</article-title><source>Stat Med</source><year>2008</year><month>01</month><day>30</day><volume>27</volume><issue>2</issue><fpage>157</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1002/sim.2929</pub-id><pub-id pub-id-type="medline">17569110</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>PWF</given-names> </name><name name-style="western"><surname>Pencina</surname><given-names>M</given-names> </name><name name-style="western"><surname>Jacques</surname><given-names>P</given-names> </name><name name-style="western"><surname>Selhub</surname><given-names>J</given-names> </name><name name-style="western"><surname>D&#x2019;Agostino</surname><given-names>R</given-names>  <suffix>Sr</suffix></name><name name-style="western"><surname>O&#x2019;Donnell</surname><given-names>CJ</given-names> </name></person-group><article-title>C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study</article-title><source>Circ Cardiovasc Qual Outcomes</source><year>2008</year><month>11</month><volume>1</volume><issue>2</issue><fpage>92</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.108.831198</pub-id><pub-id pub-id-type="medline">20031795</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alba</surname><given-names>AC</given-names> </name><name name-style="western"><surname>Agoritsas</surname><given-names>T</given-names> </name><name name-style="western"><surname>Walsh</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Discrimination and calibration of clinical prediction models: users&#x2019; guides to the medical literature</article-title><source>JAMA</source><year>2017</year><month>10</month><day>10</day><volume>318</volume><issue>14</issue><fpage>1377</fpage><lpage>1384</lpage><pub-id pub-id-type="doi">10.1001/jama.2017.12126</pub-id><pub-id pub-id-type="medline">29049590</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leening</surname><given-names>MJG</given-names> </name><name name-style="western"><surname>Vedder</surname><given-names>MM</given-names> </name><name name-style="western"><surname>Witteman</surname><given-names>JCM</given-names> </name><name name-style="western"><surname>Pencina</surname><given-names>MJ</given-names> </name><name name-style="western"><surname>Steyerberg</surname><given-names>EW</given-names> </name></person-group><article-title>Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician&#x2019;s guide</article-title><source>Ann Intern Med</source><year>2014</year><month>01</month><day>21</day><volume>160</volume><issue>2</issue><fpage>122</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.7326/M13-1522</pub-id><pub-id pub-id-type="medline">24592497</pub-id></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Q</given-names> </name><name name-style="western"><surname>Zhou</surname><given-names>S</given-names> </name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Risk assessment and stratification of mild cognitive impairment among the Chinese elderly: attention to modifiable risk factors</article-title><source>J Epidemiol Community Health</source><year>2023</year><month>08</month><volume>77</volume><issue>8</issue><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1136/jech-2022-219952</pub-id><pub-id pub-id-type="medline">37321832</pub-id></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chien</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Su</surname><given-names>TC</given-names> </name><name name-style="western"><surname>Hsu</surname><given-names>HC</given-names> </name><etal/></person-group><article-title>Constructing the prediction model for the risk of stroke in a Chinese population: report from a cohort study in Taiwan</article-title><source>Stroke</source><year>2010</year><month>09</month><volume>41</volume><issue>9</issue><fpage>1858</fpage><lpage>1864</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.110.586222</pub-id><pub-id pub-id-type="medline">20671251</pub-id></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arafa</surname><given-names>A</given-names> </name><name name-style="western"><surname>Kokubo</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Sheerah</surname><given-names>HA</given-names> </name><etal/></person-group><article-title>Developing a stroke risk prediction model using cardiovascular risk factors: the Suita study</article-title><source>Cerebrovasc Dis</source><year>2022</year><volume>51</volume><issue>3</issue><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1159/000520100</pub-id><pub-id pub-id-type="medline">34844243</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>S</given-names> </name><name name-style="western"><surname>Han</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Yu</surname><given-names>C</given-names> </name><etal/></person-group><article-title>Development of a model to predict 10-year risk of ischemic and hemorrhagic stroke and ischemic heart disease using the China Kadoorie Biobank</article-title><source>Neurology (ECronicon)</source><year>2022</year><month>06</month><day>7</day><volume>98</volume><issue>23</issue><fpage>e2307</fpage><lpage>e2317</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000200139</pub-id><pub-id pub-id-type="medline">35410902</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>C</given-names> </name><name name-style="western"><surname>Pencina</surname><given-names>MJ</given-names> </name><name name-style="western"><surname>Wojdyla</surname><given-names>DM</given-names> </name><etal/></person-group><article-title>Predictive accuracy of stroke risk prediction models across Black and White race, sex, and age groups</article-title><source>JAMA</source><year>2023</year><month>01</month><day>24</day><volume>329</volume><issue>4</issue><fpage>306</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1001/jama.2022.24683</pub-id><pub-id pub-id-type="medline">36692561</pub-id></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hageman</surname><given-names>S</given-names> </name><name name-style="western"><surname>Pennells</surname><given-names>L</given-names> </name><name name-style="western"><surname>Ojeda</surname><given-names>F</given-names> </name><etal/></person-group><article-title>SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe</article-title><source>Eur Heart J</source><year>2021</year><month>07</month><day>1</day><volume>42</volume><issue>25</issue><fpage>2439</fpage><lpage>2454</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehab309</pub-id></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amarenco</surname><given-names>P</given-names> </name></person-group><article-title>Five-year risk of stroke after TIA or minor ischemic stroke</article-title><source>N Engl J Med</source><year>2018</year><month>10</month><day>18</day><volume>379</volume><issue>16</issue><fpage>1579</fpage><lpage>1581</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1808913</pub-id></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names> </name><name name-style="western"><surname>Burgess</surname><given-names>S</given-names> </name><name name-style="western"><surname>Micha&#x00EB;lsson</surname><given-names>K</given-names> </name></person-group><article-title>Smoking and stroke: a mendelian randomization study</article-title><source>Ann Neurol</source><year>2019</year><month>09</month><volume>86</volume><issue>3</issue><fpage>468</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1002/ana.25534</pub-id><pub-id pub-id-type="medline">31237718</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q</given-names> </name><name name-style="western"><surname>Yan</surname><given-names>S</given-names> </name><name name-style="western"><surname>Li</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Kang</surname><given-names>H</given-names> </name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names> </name><name name-style="western"><surname>Lv</surname><given-names>C</given-names> </name></person-group><article-title>Mendelian randomization study of heart failure and stroke subtypes</article-title><source>Front Cardiovasc Med</source><year>2022</year><volume>9</volume><issue>844733</issue><fpage>35463787</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2022.844733</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beheshti</surname><given-names>S</given-names> </name><name name-style="western"><surname>Madsen</surname><given-names>CM</given-names> </name><name name-style="western"><surname>Varbo</surname><given-names>A</given-names> </name><name name-style="western"><surname>Benn</surname><given-names>M</given-names> </name><name name-style="western"><surname>Nordestgaard</surname><given-names>BG</given-names> </name></person-group><article-title>Relationship of familial hypercholesterolemia and high low-density lipoprotein cholesterol to ischemic stroke: Copenhagen General Population Study</article-title><source>Circulation</source><year>2018</year><month>08</month><day>7</day><volume>138</volume><issue>6</issue><fpage>578</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.033470</pub-id><pub-id pub-id-type="medline">29593013</pub-id></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valdes-Marquez</surname><given-names>E</given-names> </name><name name-style="western"><surname>Parish</surname><given-names>S</given-names> </name><name name-style="western"><surname>Clarke</surname><given-names>R</given-names> </name><etal/></person-group><article-title>Relative effects of LDL-C on ischemic stroke and coronary disease: a Mendelian randomization study</article-title><source>Neurology (ECronicon)</source><year>2019</year><month>03</month><day>12</day><volume>92</volume><issue>11</issue><fpage>e1176</fpage><lpage>e1187</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000007091</pub-id><pub-id pub-id-type="medline">30787162</pub-id></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bahls</surname><given-names>M</given-names> </name><name name-style="western"><surname>Leitzmann</surname><given-names>MF</given-names> </name><name name-style="western"><surname>Karch</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Physical activity, sedentary behavior and risk of coronary artery disease, myocardial infarction and ischemic stroke: a two-sample Mendelian randomization study</article-title><source>Clin Res Cardiol</source><year>2021</year><month>10</month><volume>110</volume><issue>10</issue><fpage>1564</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1007/s00392-021-01846-7</pub-id><pub-id pub-id-type="medline">33774696</pub-id></nlm-citation></ref><ref id="ref38"><label>38</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>H</given-names> </name><name name-style="western"><surname>Shao</surname><given-names>S</given-names> </name><name name-style="western"><surname>Liu</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Age- and sex-associated impacts of body mass index on stroke type risk: a 27-year prospective cohort study in a low-income population in China</article-title><source>Front Neurol</source><year>2019</year><volume>10</volume><issue>456</issue><fpage>456</fpage><pub-id pub-id-type="doi">10.3389/fneur.2019.00456</pub-id><pub-id pub-id-type="medline">31118920</pub-id></nlm-citation></ref><ref id="ref39"><label>39</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names> </name><name name-style="western"><surname>Wen</surname><given-names>X</given-names> </name><name name-style="western"><surname>Li</surname><given-names>W</given-names> </name><name name-style="western"><surname>Li</surname><given-names>X</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Lu</surname><given-names>W</given-names> </name></person-group><article-title>Risk factors for stroke in the Chinese population: a systematic review and meta-analysis</article-title><source>J Stroke Cerebrovasc Dis</source><year>2017</year><month>03</month><volume>26</volume><issue>3</issue><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2016.12.002</pub-id><pub-id pub-id-type="medline">28041900</pub-id></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>Supplementary data to this article can be found in Multimedia Appendix 1.</p><media xlink:href="publichealth_v11i1e72497_app1.docx" xlink:title="DOCX File, 4311 KB"/></supplementary-material></app-group></back></article>